<VariationArchive RecordType="classified" VariationID="375412" VariationName="NM_005536.4(IMPA1):c.489_493dup (p.Ser165fs)" VariationType="Duplication" Accession="VCV000375412" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2022-04-11" MostRecentSubmission="2022-04-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="362179" VariationID="375412">
      <GeneList>
        <Gene Symbol="IMPA1" FullName="inositol monophosphatase 1" GeneID="3612" HGNC_ID="HGNC:6050" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q21.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="81656914" stop="81686325" display_start="81656914" display_stop="81686325" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="82569150" stop="82598588" display_start="82569150" display_stop="82598588" Strand="-" />
          </Location>
          <OMIM>602064</OMIM>
          <Haploinsufficiency last_evaluated="2012-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IMPA1">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IMPA1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005536.4(IMPA1):c.489_493dup (p.Ser165fs)</Name>
      <CanonicalSPDI>NC_000008.11:81671011:AGCCCA:AGCCCAGCCCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q21.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="81671011" stop="81671012" display_start="81671011" display_stop="81671012" variantLength="5" positionVCF="81671011" referenceAlleleVCF="G" alternateAlleleVCF="GAGCCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="82583246" stop="82583247" display_start="82583246" display_stop="82583247" variantLength="5" positionVCF="82583246" referenceAlleleVCF="G" alternateAlleleVCF="GAGCCC" />
      </Location>
      <ProteinChange>S165fs</ProteinChange>
      <ProteinChange>S224fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.82583248_82583252dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.82583248_82583252dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.81671013_81671017dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.81671013_81671017dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015829.1" sequenceAccession="NG_015829" sequenceVersion="1" change="g.20339_20343dup">
            <Expression>NG_015829.1:g.20339_20343dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144878.2" sequenceAccession="NM_001144878" sequenceVersion="2" change="c.666_670dup">
            <Expression>NM_001144878.2:c.666_670dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138350.1" sequenceAccession="NP_001138350" sequenceVersion="1" change="p.Ser224fs">
            <Expression>NP_001138350.1:p.Ser224fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005536.4" sequenceAccession="NM_005536" sequenceVersion="4" change="c.489_493dup" MANESelect="true">
            <Expression>NM_005536.4:c.489_493dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005527.1" sequenceAccession="NP_005527" sequenceVersion="1" change="p.Ser165fs">
            <Expression>NP_005527.1:p.Ser165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144879.2" sequenceAccession="NM_001144879" sequenceVersion="2" change="c.457+2825_457+2829dup">
            <Expression>NM_001144879.2:c.457+2825_457+2829dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16044248" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602064.0001" DB="OMIM" />
        <XRef Type="rs" ID="1057519491" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005536.4(IMPA1):c.489_493dup (p.Ser165fs) AND Intellectual disability, autosomal recessive 59" Accession="RCV000416531" Version="4">
        <ClassifiedConditionList TraitSetID="34973">
          <ClassifiedCondition DB="MedGen" ID="C4310619">Intellectual disability, autosomal recessive 59</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-04-11" MostRecentSubmission="2022-04-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26416544</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32839513</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="34973" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36854" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal recessive 59</ElementValue>
                <XRef ID="MONDO:0015020" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRT59</ElementValue>
                <XRef Type="MIM" ID="617323" DB="OMIM" />
              </Symbol>
              <XRef ID="C4310619" DB="MedGen" />
              <XRef ID="MONDO:0015020" DB="MONDO" />
              <XRef Type="MIM" ID="617323" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="966715" SubmissionDate="2022-04-07" DateLastUpdated="2022-04-11" DateCreated="2017-02-05">
        <ClinVarSubmissionID localKey="602064.0001_INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59 (1 family)" title="IMPA1, 5-BP DUP, 489GGGCT_INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59 (1 family)" />
        <ClinVarAccession Accession="SCV000494290" DateUpdated="2022-04-11" DateCreated="2017-02-05" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamilies="1" />
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 9 affected members of a large consanguineous Brazilian family with autosomal recessive intellectual developmental disorder-59 (MRT59; 617323), Figueiredo et al. (2016) identified a homozygous 5-bp duplication (c.489_493dupGGGCT, NM_005536) in the IMPA1 gene, resulting in a frameshift and premature termination (Ser165TrpfsTer10). The mutation, which was found by a combination of autozygosity mapping and exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. A total of 26 family members were genotyped. The mutation was not found in the ExAC database or in 1,484 Brazilian controls. Plasma and urine levels of myoinositol or phosphoinositol in patients were similar to those in heterozygous carriers and controls. Brain imaging and magnetic resonance spectroscopy, performed in 1 patient, were normal. Specifically, there was no reduction in the myoinositol peak. However, Figueiredo et al. (2016) speculated that loss of IMPA1 activity may affect intracellular signaling within neurons and/or neurotransmitter release.</Attribute>
              <Citation>
                <ID Source="PubMed">26416544</ID>
              </Citation>
              <XRef DB="OMIM" ID="617323" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">By transcriptome analysis, Figueiredo et al. (2021) showed that the IMPA1 loss-of-function mutation modified the gene expression profile in neuronal progenitor cells (NPCs) derived from induced pluripotent stem cells (iPSCs) generated from patients with intellectual disability from the Brazilian family reported by Figueiredo et al. (2016). IMPA1 deficiency specifically affected survival and proliferation of NPCs and decreased the capacity of iPSC and NPCs to differentiate into neurons. However, IMPA1 deficiency did not affect astrocyte differentiation from glial precursors cell, indicating that the effect of IMPA1 loss of function on neuronal defects was cell autonomous.</Attribute>
              <Citation>
                <ID Source="PubMed">32839513</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">26416544</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IMPA1" />
          </GeneList>
          <Name>IMPA1, 5-BP DUP, 489GGGCT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DUP, 489GGGCT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602064.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59 (1 family)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

